Regular paperThe vesicular monoamine transporter is not regulated by dopaminergic drug treatments
References (39)
Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors
Biochem. Pharmacol.
(1989)- et al.
Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin
Neuroscience
(1989) - et al.
In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain
Life Sci.
(1992) - et al.
Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex
Peptides
(1990) Storage and release of neurotransmitters
Neuron
(1993)- et al.
Repeated reserpine administration reduces in vivo [18F]GBR-13119 binding to the dopamine uptake site
Eur. J. Pharmacol.
(1992) - et al.
Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is strereospecific
Eur. J. Pharmacol.
(1995) - et al.
Autoradiographic visualization of dopamine D2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride
Neurosci. Lett.
(1986) - et al.
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats
Life Sci.
(1979) - et al.
[3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum
Neurosci. Lett.
(1990)
Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptor
Life Sci.
(1978)
Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter
Neurosci. Lett.
(1994)
Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens
Eur. J. Pharmacol.
(1991)
[3H]Methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity
Neuroscience
(1995)
Chronic l-deprenyl induced up-regulation of the dopamine uptake carrier
Eur. J. Pharmacol.
(1989)
Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum
Eur. J. Pharmacol.
(1993)
Unaltered [3H]GBR-12935 binding after chronic treatment with deopamine active drugs
Psychopharmacology
(1990)
In vivo evaluation of striatal dopamine re-uptake site using C-11-nomifensine and positron emission tomography
Acta Neurol. Scand.
(1987)
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain
Science
(1977)
Cited by (0)
Copyright © 1995 Published by Elsevier B.V.